HK Stock Market Move | ANDRE JUICE (02218) fell more than 4% after the announcement of its results, with revenue from main business operations in the first half of the year decreasing by 24.49% year-on-year.
Andeli Juice (02218) fell over 4% after earnings report, as of the time of publication, down 4.05%, priced at HK$19.92, with a trading volume of HK$18.7935 million.
ANDRE JUICE (02218) dropped over 4% after its earnings report, falling 4.05% to HK$19.92 as of the time of writing, with a transaction volume of HK$18.7935 million.
In terms of news, on August 24, ANDRE JUICE announced its interim results for 2026, reporting an operating revenue of approximately RMB 716 million, a year-on-year decrease of 24.45%; the net profit attributable to shareholders of the listed company was about RMB 123 million, a year-on-year decrease of 38.71%; with basic earnings per share at RMB 0.37. The announcement stated that the decline in revenue was mainly due to a decrease in both the sales volume and selling prices of concentrated fruit juice during the reporting period.
On the same day, ANDRE JUICE released its key operational data for the first half of 2026, stating that the revenue from its main business was about RMB 714 million, a year-on-year decrease of 24.49%. Of this, the revenue from juice and flavors amounted to approximately RMB 693 million, a year-on-year decrease of 24.41%, while the revenue from feed was approximately RMB 21.2116 million, a year-on-year decrease of 26.75%.
Related Articles

HK Stock Market Move | InnoCare Pharma (09969) rose over 4% as strong growth in its commercialized products coupled with business development achievements led to a turnaround in profits in the first half of the year compared to the same period last year.

HK Stock Market Move | SUNAC (01918) rose over 9% in early trading, officially announcing its transformation to "asset management + asset operation," and has acquired management of all equity to date.

HK Stock Market Move | CHI SILVER GP (00815) fell over 5%, expecting a mid-term net loss of 15 million to 25 million yuan, as the companys silver ingot sales declined.
HK Stock Market Move | InnoCare Pharma (09969) rose over 4% as strong growth in its commercialized products coupled with business development achievements led to a turnaround in profits in the first half of the year compared to the same period last year.

HK Stock Market Move | SUNAC (01918) rose over 9% in early trading, officially announcing its transformation to "asset management + asset operation," and has acquired management of all equity to date.

HK Stock Market Move | CHI SILVER GP (00815) fell over 5%, expecting a mid-term net loss of 15 million to 25 million yuan, as the companys silver ingot sales declined.

RECOMMEND





